Apidra SoloStar Units/ml solution for injection in a pre-filled pen – Patient The Patient Information Leaflet (PIL) is the leaflet included in the pack with a. Apidra SoloStar Units/ml solution for injection in a pre-filled pen . SoloStar, the Instructions for use included in the Package leaflet must be read carefully. APIDRA [insulin glulisine injection (rDNA origin)] is a recombinant . package insert, and the pump manufacturer’s manual (see DOSAGE AND.

Author: Meztisho Magul
Country: Eritrea
Language: English (Spanish)
Genre: Education
Published (Last): 6 April 2006
Pages: 156
PDF File Size: 6.27 Mb
ePub File Size: 6.4 Mb
ISBN: 284-5-91980-771-9
Downloads: 92316
Price: Free* [*Free Regsitration Required]
Uploader: Tell

This site uses cookies. Fibric acid derivatives may enhance the hypoglycemic effects of antidiabetic agents through increased insulin sensitivity and decreased glucagon secretion.

In addition, compared with subcutaneous administration, insulin glulisine administered IV has a quicker onset of action. Some patients may require adjustment to their hypoglycemic medications over time. If your blood sugar is too high hyperglycaemiayou inxert not have injected enough insulin. Intermittent SC injections of insulin glulisine should be given within 15 minutes before to 20 minutes after starting a meal because of it’s rapid onset compared to regular insulin.

Pharmacopeia Dispensing Information USP DI recommends that an opened insulin vial may be kept at room temperature for up to one month usually defined as 28 to 30 days.

To prevent the possible transmission of disease, each pen must be used by one patient only. Fever, thyroid disease, infection, recent trauma or surgery, diarrhea secondary to malabsorption, vomiting, and certain medications can also affect insulin requirements, requiring dosage adjustments. This should be taken into consideration in patients with impaired glucose tolerance or diabetes mellitus who are receiving antidiabetic agents.

Continue typing to refine. Check if insulin comes out of the needle tip. Follow the same steps for your insulin glulisine dose, but do not apiddra the needle. Insulin is filtered and reabsorbed by the kidneys; the plasma half-life of human endogenous insulin is approximately 5—6 minutes.


Monitor blood sugar and adjust insulin dosage as clinically indicated.

Moderate Monitor blood glucose carefully when packag quinolones and antidiabetic agents, including insulin, are coadministered. Before use always attach a new needle, and perform a safety test.

Fast-Acting, Mealtime Insulin | Apidra® (insulin glulisine [rDNA origin] injection)

It has a rapid onset within minutes and a short duration, about 4 hours. Your Name Your name is required. Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. Thus, salicylates can decrease blood glucose concentrations. Insulin Mix-ups You must always check the insulin label before each injection to avoid mix-ups between Apidra and other insulins.

How to store Apidra Keep this medicine out of the sight and reach of children. Always attach a new needle before each use.

Inserg Diazoxide, when administered intravenously or orally, produces a prompt dose-related increase in blood glucose level, due primarily to an inhibition of insulin release from the pancreas, and also to an extrapancreatic effect. Pull back the plunger of a disposable syringe to fill the syringe with an amount of air equal to your dose of insulin if your dose is 30 units, pull the plunger to the 30 unit mark. Making sure the tip of the needle is in the insulin, pull back on the plunger to fill the syringe with the prescribed number of units of insulin.

This pen is only for your use. Moderate Sodium polystyrene apidfa should be used cautiously with other agents that can induce hypokalemia such as loop diuretics, insulins, or intravenous sodium bicarbonate. If you have any further questions, ask your doctor, pharmacist or nurse. Do not use this SoloStar if the insulin is cloudy, coloured or has particles. Diuretic-induced hypokalemia may also lead to hyperglycemia. Monitor patients for increase in triglyceride concentrations.

Lightly pinch a fold of skin; insert the needle; release the skin; inject at a 90 degree angle.


PDR Search

Patients receiving antidiabetic agents should monitor their blood glucose levels frequently due to this potential pharmacodynamic interaction. Frequency of administration Apidra should be taken shortly minutes before or soon after meals.

Since beta blockers inhibit the release of catecholamines, these medications may hide symptoms of hypoglycemia such as tremor, tachycardia, and blood pressure changes.

Inhibitors of MAO type A have been shown to pacage the hypoglycemic response to insulin and oral sulfonylureas. Moderate Monitor patients receiving octreotide concomitantly with insulin or other antidiabetic agents for changes in glycemic control and adjust doses of these medications accordingly. Before removing the needle from the vial, check your syringe for air bubbles.

Acetaminophen; Chlorpheniramine; Dextromethorphan; Pseudoephedrine: It may be necessary to adjust the dose of antidiabetic agents if thyroid hormones are added or discontinued.

Insulin glulisine in an external pump reservoir should be discarded after 48 hours of use. Moderate Coadministration of metformin with an insulin may increase the risk of hypoglycemia. Instructions for proper use How to handle SoloStar SoloStar is a pre-filled disposable pen containing insulin glulisine.

Inser Triamterene can decrease the hypoglycemic effects of insulin by producing an increase in blood glucose levels.

In addition, diuretics reduce the risk of stroke and cardiovascular disease in patients with diabetes. Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse.

Remove the needle from the skin and press gently on the injection site for a moment but do not rub or inssrt. Serious hypoglycaemia may cause brain damage and may be life-threatening. Moderate Estramustine may decrease glucose tolerance leading to hyperglycemia.